TransCode Therapeutics Announces Closing of $7.25 Million Public Offering
22 janv. 2024 16h45 HE
|
TransCode Therapeutics, Inc.
TransCode Therapeutics closes public offering
TransCode Therapeutics To Participate at H.C. Wainwright BioConnect Conference
06 janv. 2022 15h17 HE
|
TransCode Therapeutics, Inc.
BOSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that it will be attending and presenting at the H.C. Wainwright BioConnect Conference....